Claire Aldridge, Ph.D.
elected Claire Aldridge, Ph.D., as a director of the Company, effective March 14, 2025
Highest-materiality recent filing
Alexandria Real Estate Equities issues $750M of 5.25% Senior Notes due 2036
Issued $750M aggregate principal of 5.25% Senior Notes due March 15, 2036.
Joel S. Marcus's 2025 LTI grant changed to 100% performance-based vesting with max value of $5,400,000, up from prior $4,500,000.
Alexandria Co-President Ryan resigns; Board authorizes new $500M stock repurchase program
Daniel J. Ryan, Co-President and San Diego Regional Market Director, resigns effective Dec 31, 2025 for personal/health reasons.
Alexandria REIT provides initial 2026 FFO/share guidance of $6.25-$6.85 amid occupancy challenges
Operating occupancy dropped to 90.6% (Sept 30, 2025) from 94.7% a year ago, a four-quarter decline.
Alexandria RE issues $550M of 5.50% Senior Notes due 2035
Issued $550M aggregate principal amount of 5.50% Senior Notes due 2035.
Alexandria RE prices $550M 5.50% senior notes due 2035; proceeds to refinance 2025 debt
Priced $550M aggregate principal amount of 5.50% senior notes due 2035 at 99.733% of par (yield 5.532%).
Alexandria Real Estate sues NYC Health+Hospitals and EDC over floodwall dispute; $161.5M at risk
ARE subsidiary invested $161.5M in pre-construction costs for third tower at Alexandria Center for Life Science – NYC as of June 30, 2024.
Alexandria Real Estate Equities enters $1.5B at-the-market stock sale agreement
Up to $1.5B in common stock offered via distribution agreement with 18 sales agents and forward purchasers.
elected Claire Aldridge, Ph.D., as a director of the Company, effective March 14, 2025
Max materiality 0.80 · Median 0.50 · Most common event earnings